Increased risk of exacerbating gastrointestinal disease among elderly patients following treatment with calcium channel blockers

Journal of Clinical Pharmacy and Therapeutics

Volumn 33, Issue 6, 2008, Pages 619-624

  Hamada, A ^a   Ishii, J ^a   Doi, K ^a   Hamada, N ^a   Miyazaki, C ^a   Hamada, T ^a   Ohwaki, Y ^a   Wada, M ^a   Nakashima, K ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Antisecretory drug; Calcium channel blocker; Community pharmacy; Elderly patient; Gastrointestinal disease

Indexed keywords

AMLODIPINE; AZELNIDIPINE; BENIDIPINE; CALCIUM CHANNEL BLOCKING AGENT; CILNIDIPINE; CIMETIDINE; DILTIAZEM; EFONIDIPINE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; MANIDIPINE; NIFEDIPINE; NILVADIPINE; NIZATIDINE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE; STOMACH SECRETION INHIBITOR; VERAPAMIL;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; JAPAN; LONG TERM CARE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; CALCIUM CHANNEL BLOCKERS; COHORT STUDIES; ESOPHAGEAL SPHINCTER, LOWER; FEMALE; GASTROINTESTINAL DISEASES; HISTAMINE H2 ANTAGONISTS; HUMANS; JAPAN; MALE; MIDDLE AGED; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES;

EID: 55949085773     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2008.00958.x     Document Type: Article

References (18)

1. Hansson L, Lindholm LH, Ekbom T et al. (1999) Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the swedish trial in old patients with hypertension-2 study. Lancet, 354, 1751 1756.
2. National Intervention Cooperative Study in Elderly Hypertensives Study Group. (1999) Randomized double-blind comparison of a calcium antagonist and a diuretic in elderly hypertensives. Hypertension, 34, 1129 1133.
3. Ogihara T (2000) Practitioner's trial on the efficacy of antihypertensive treatment in the elderly hypertension (The PATE-Hypertension Study) in Japan. American Journal of Hypertension, 13, 461 467.
4. Gong L, Zhang W, Zhu Y, Zhu J (1996) Shanghai trial of nifedipine in the elderly (STONE). Journal of Hypertension, 14, 1237 1245.
5. Staessen JA, Fagard R, Thijs L et al. (1997) Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet, 350, 757 764.
6. Liu L, Wang JG, Gong L, Liu G, Staessen JA (1998) Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Journal of Hypertension, 16, 1823 1829.
7. Alberto P (2004) Aging and upper gastrointestinal disorders. Best Practice and Research Clinical Gastroenterology, 18, 73 81.
8. Hongo M, Traube M, McAllister RG Jr., McCallum RW (1984) Effects of nifedipine on esophageal motor function in humans: correlation with plasma nifedipine concentration. Gastroenterology, 86, 8 12.
9. Blackwell JN, Holt S, Heading RC (1981) Effect of nifedipine on oesophageal motility and gastric emptying. Digestion, 21, 50 56.
10. Becker BS, Burakoff R (1983) The effect of verapamil on the lower esophageal sphincter pressure in normal subjects and achalasia. American Journal of Gastroenterology, 78, 773 775.
11. Konrad-Dalhoff I, Baunack AR, Rämsch KD et al. (1991) Effect of the calcium antagonists nifedipine, nitrendipine, nimodipine and nisoldipine on oesophageal motility in man. European Journal of Clinical Pharmacology, 41, 313 316.
12. Traube M, Hongo M, Magyar L, McCallum RW (1984) Effects of nifedipine in achalasia and in patients with high amplitude peristaltic esophageal contractions. Journal of the American Medical Association, 252, 1733 1736.
13. Allen M, Mellow M, Robinson MG, Orr WC (1987) Comparison of calcium channel blocking agents and an anticholinergic agent on esophageal function. Alimentary Pharmacology and Therapeutics, 1, 153 159.
14. Chow SL, Luzier AB, DiTusa L, Snyder BD, Izzo JL Jr. (2001) Acid-suppressive therapy use associated with antihypertensive agents. Journal of Clinical Pharmacology, 41, 750 756
15. Habu Y, Yoshino T, Shio S, Hayakumo T, Kawai K (2004) Evaluation of the efficacy and the cost-effectiveness of maintenance treatment of gastroesophageal reflux disease: proton pump inhibitor versus histamine-2-receptor antagonist. Nippon Rinsho, 62, 1504 1509
16. Wu JH, Chang CS, Chen GH, Poon SK, Ko CW (2000) Felodipine does not increase the reflux episodes in patients with gastroesophageal reflux disease. Hepato-Gastroenterology, 47, 1328 1331
17. Jenkinson LR, Norris TL, Watson A (1988) Gastro-oesophageal reflux associated with nifedipine. Alimentary Pharmacology and Therapeutics, 2, 337 339
18. Heidenreich PA, McDonald KM, Hastie T, Fadel B, Hagan V, Lee BK, Hlatky MA (1997) Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina. Journal of the American Medical Association, 281, 1927 1936